Request for Quotation (RFQ) for the provision of accredited biosimilar characterisation services for locally produced Bevacizumab monoclonal antibody, in compliance with SAHPRA and WHO guidelines, to the CSIR

Request for Quotation (RFQ) for the provision of accredited biosimilar characterisation services for locally produced Bevacizumab monoclonal antibody, in compliance with SAHPRA and WHO guidelines, to the CSIR

Tender Number

CSIR RFQ 9519/18/11/2025

Details

Request for Quotation (RFQ) for the provision of accredited biosimilar characterisation services for locally produced Bevacizumab monoclonal antibody, in compliance with SAHPRA and WHO guidelines, to the CSIR

CSIR Material Transfer Agreement 

NOTICE OF TENDER CANCELLATION

 

Publication Date

Tender Status

Cancelled

Closing Date

Submissions

tender@csir.co.za

Tender Cancellation Reason

Funds allocated are not available to cover the total envisaged expenditure.